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ABSTRACT
Magnetic nanoparticles for Bio-analytical Applications
Sri Lakshmi Yedlapalli

Magnetic nanoparticles are widely being used in various fields of medicine,
biology and separations. This dissertation focuses on the synthesis and use of
magnetic nanoparticles for targeted drug delivery and analytical separations. The
goals of this research include synthesis of biocompatible surface modified
monodisperse superparamagnetic iron oxide nanoparticles (SPIONs) by novel
techniques for targeted drug delivery and use of SPIONs as analytical sensing
tools. Surface modification of SPIONs was performed with two different copolymers: tri block copolymer Pluronics and octylamine modified polyacrylic acid.
Samples of SPIONs were subsequently modified with 4 different commercially
available, FDA approved tri-block copolymers (Pluronics), covering a wide range
of molecular weights (5.75-14.6 kDa). A novel, technically simpler and faster
phase transfer approach was developed to surface modify the SPIONs with
Pluronics for drug delivery and other biomedical applications. The hydrodynamic
diameter and aggregation properties of the Pluronic modified SPIONs were
studied by dynamic light scattering (DLS). The coverage of SPIONs with
Pluronics was supported with IR Spectroscopy and characterized by Thermo
gravimetric Analysis (TGA). The drug entrapment capacity of SPIONs was
studied by UV-VIS spectroscopy using a hydrophobic carbocyanine dye, which
serves as a model for hydrophobic drugs. These studies resulted in a
comparison of physical properties and their implications for drug loading
capacities of the four types of Pluronic coated SPIONs for drug delivery
assessment. These drug delivery systems could be used for passive drug
targeting. However, Pluronics lack the functional group necessary for
bioconjugation and hence cannot achieve active targeting.

SPIONs were functionalized with octylamine modified polyacrylic acid-based
copolymer, providing water solubility and facile biomolecular conjugation.
Epirubicin was loaded onto SPIONs and the drug entrapment was studied by UVVIS spectrophotometry. In this study, the antisense oligonucleotide sequence to
the anti-apoptopic protein survivin was coupled to SPIONs to provide molecular
targeting and potential therapy for cancer cells. Successful coupling of antisense
survivin to SPIONs was demonstrated by circular dichroism studies of the
conjugate and its complementary sequence. Such multifunctional SPIONs can be
used as active targeting agents for cancer cells, producing enhanced magnetic
resonance imaging contrast and releasing chemotherapeutic agents to targeted
cells.
SPIONs also serve as an excellent platform for analytical sensing. Streptavidin
modified SPIONs were used as substrates to immobilize biotinylated aptamers
(single-stranded DNA). The binding affinity of such aptamers to its target was
achieved by quantifying the amount of target released from the aptamer. This
quantification

was

achieved

using

pH-mediated

stacking

capillary

electrophoresis. SPIONs were shown to be more efficient compared to magnetic
microbeads as the sensing elements. The binding affinity constant of the aptamer
determined was almost 8-fold better than that obtained using magnetic
microbeads.
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Chapter 1: Introduction
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Nanoparticles, due to their size, offer a number of special optical1, electronic2
properties. The physico-chemical properties of nanoparticles differ vastly
depending on their dimensions, charge, hydrophobicity and the surface coating.
Magnetic nanoparticles have an additional property of responding to magnetic
field.3

Magnetic particles ranging from nanometer (nm) to micrometer (um) size are
widely being used in the various fields such as sensing, diagnostics and drug
delivery.4,

5

Successful application of the nanoparticles in these areas is highly

dependent on the stability of these particles under different aqueous and
physiological conditions. The ability to solubilize the nanoparticles in water and to
modify their surface with molecules, proteins or other targeting agents is a crucial
step for their biomedical applications and bioanalysis.6

In the last two decades, the use of magnetic nanoparticles in biomedical
applications has been increasing, especially in the treatment of cancer through
tumor targeting. Though there are different ways to treat cancer, such as surgery,
radiation, chemotherapy etc., the most widely used approach is chemotherapy,
but there are a number of limitations with conventional chemotherapeutic
approaches. The major disadvantage in conventional chemotherapeutic
approaches for cancer treatment is non-specificity that results in undesirable side
effects.7 The use of nanoparticles as drug delivery vectors can revolutionize
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cancer therapy. Magnetic nanoparticles can be used to target specific site of
cancer. As nanoparticles are very small, they are easily accepted by cells, and
hence many small molecules, nucleic acids, peptides are being loaded into
nanoparticles and targeted to the specific tissues. SPIONs are FDA approved
and are being used in clinical applications.8

Using nanoparticles in drug delivery reduces the drug dose and improves drug
efficiency. Since most normal tissues have non-leaky microvasculature, long
circulating nanoparticles accumulate to a greater extent in the leaky tumor tissue
with poor lymphatic drainage system. This passive targeting of the drug is
achieved by enhanced permeability and retention effect. Prolonged circulation of
the drug results in better targeting efficiency due to greater accumulation of drug
particles in the tumor tissue.9

Figure 1-1: Accumulation of nanoparticles by Enhanced permeability and
retention effect [Passive targeting]
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Iron Oxide is the most commonly used metal in nanoparticle formulations. Two
types of Iron oxides have been investigated for use in magnetic nanoparticle
formulations:

Maghemite

[γ-Fe2O3]

and

Magnetite

[Fe3O4].

Magnetic

nanoparticles are potentially used in biomedical applications due to their high
stability and non-toxic nature.6

Depending on the size of the magnetic nanoparticles, they are named as
superparamagnetic iron oxide nanoparticles (SPIONs).

A superparamagnetic

material is composed of small ferromagnetic crystallites which randomly flip their
magnetic moment direction under thermal fluctuations. As a result, the material
as a whole is not magnetized except in an externally applied magnetic field
(similar to paramagnetic material). Due to this magnetic nature, SPIONs can be
used as site specific release drug carriers, magnetic resonance imaging (MRI)
agents and in hyperthermia. SPIONs with core sizes ranging from 3 to 10 nm
with dextran polymer coating are approved for use as MRI contrast agents in
patients. Commercially available iron oxide formulations for MRI include Ferridex,
Combidex and Sinerem.10

1.3 Synthesis of magnetic iron oxide nanoparticles
Iron Oxide Nanoparticles were produced by many different methods. These
include co-precipitation, thermal decomposition, microemulsion and hydrothermal
synthesis11. However, thermal decomposition is preferred in terms of size and
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morphology control of nanoparticles.12 Table-1 shows the summary comparison
of the synthetic methods.

Table 1-1: Summary comparison of the synthetic methods.

Synthetic

Synthesis

Solvent

method
Co-precipitation

Very simple,

Water

ambient

Size

Shape

Yield

Distribution

control

Relatively

Not

High/

narrow

good

scalable

Very narrow

Very

High/

good

Scalable

Good

Low

Very

medium

conditions
Thermal

Complicated,

Organic

decomposition

inert

compound

atmosphere
microemulsion

Complicated,

Organic

Relatively

ambient

compound

narrow
Very narrow

conditions
Hydrothermal

Simple, high

Water

synthesis

pressure

ethanol

good

For all these methods a surface capping agent is needed and added during the
synthesis.
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1.2 Surface modifications on magnetic nanoparticles
Size and surface characteristics are two important parameters which highly
dictate particle stability and interactions of the particles with biological
environment.
biomolecules,

To
they

make
must

these

nanoparticles

undergo

surface

biocompatible
modifications.4,

and
13

attach

Magnetic

nanoparticles have been surface modified with different polymers such as
polyethylene glycol (PEG), polyacrylic acid (PAA), polyvinyl alcohol (PVA),
dextran etc. Alteration of the surface chemistry and physical properties enables
in preparation of functional magnetic nanoparticles apart from providing
increased stability. Stabilization of nanoparticles by surfactants or polymers can
be due to electrostatic repulsion of surface charges or steric stabilization.
Polymers can attach to nanoparticles by physical adsorption due to weak Vander
Waals forces, dipole-dipole interactions or hydrogen bonds and chemical
adsorption by electrostatic or covalent bonds. Surface modified nanoparticles
also help in coupling of drugs by covalent attachment, adsorption or entrapment.
Target biomolecules such as antibodies and nucleic acids can also be
conjugated to functionalized nanoparticles. Thus, surface engineering of
nanoparticles results in their applications in various fields.

1.3 Bio-analytical applications of magnetic nanoparticles
In the last two decades, magnetic nanoparticles are extensively being used in
number of bioanalytical applications.4,

14, 15

The use of magnetic nanoparticles

can be classified based on their in vivo and in vitro applications. In vivo
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applications of magnetic nanoparticles includes their effective use as contrast
agents in magnetic resonance imaging (MRI), selective destruction of malignant
tissues through heating by a technique called hyperthermia and as site selective
delivery vehicles for drugs. In vitro applications of magnetic nanoparticles include
their use as separation tools in nano and microfluidic devices as well as
biological or immunoassays. Figure 1-2 shows some of the applications of
magnetic nanoparticles.

Diagnostics

Hyperthermia

Biosensors
Magnetic
nanoparticles

Separations

Drug
delivery

Figure 1-2: Applications of magnetic nanoparticles
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1.3.1 Drug targeting
SPIONs can deliver the drug to the site of interest by passive, active and physical
targeting. In passive targeting, drug is delivered to the specific sites by the
special properties of carriers. In active targeting, drug is delivered to specific sites
by special recognition mechanisms. A key advantage to utilizing SPIONs for drug
targeting is that in physical targeting, drug is delivered to the specific site by
means of external forces such as magnetic field.6

Colloidal systems with sizes below 500 nm are used as drug carrier systems
which include microparticles, nano and microemulsions apart from nanoparticles.
There are several vital factors such as size, mobility, surface charge, toxicity,
density and molecular weight which play an important role in the distribution of
these carrier systems within the body system.

1.3.1.2 Intake of nanoparticles by cells
The size of nanoparticles plays an important role in the uptake and elimination of
nanoparticles or nano drug delivery vehicles.16 The mechanism of cellular uptake
of nanoparticles has been investigated previously. Almost all the nanoparticles
used for biological applications are hydrophilic and are dispersed in aqueous
solutions. These particles cannot pass through the hydrophobic plasma or cell
membrane. Nanoparticles are known to be taken up by the cells by endocytosis
mechanism.16,

17

Endocytosis is a process wherein the plasma membrane

invaginates to form vesicles that can enclose the extracellular components and
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take them up into the cells. There are several types of endocytosis including
receptor mediated endocytosis, phagocytosis (cell eating) and pinocytosis (cell
drinking). Reportedly, nanoparticles enter the cells via receptor/clathrin-mediated
endocytosis.17 In this type of endocytosis, clathrin protein coated pits are formed
in the plasma/cell membrane when the target particles bind to the receptor
proteins on the plasma membrane and buds to form cytoplasmic vesicles.18

1.3.2 Magnetic Resonance Imaging
Magnetic resonance imaging is based on the principles of NMR. It is a widely
used non-invasive diagnostic method mainly for soft tissues and cartilages based
on the difference in relaxation times of hydrogen atoms. SPIONs are widely used
as MRI contrast agents due to this difference in hydrogen atom relaxation
times.19 However, use of SPIONs depends on its physicochemical properties
such as size, surface charge and surface coatings. Biocompatible surface
coatings such as dextran, starch, poly vinyl acid, polyacrylic acid and poly
ethylene glycol have been used on SPIONs.20-23 The efficacy of SPIONs as MRI
contrast agents can be increased by using biologically active ligands like
antibodies, DNA and proteins for surface modification. Currently, a number of
SPIONs exist in clinical trials or involved in experimental study stages, examples
including Lumiren® for bowel imaging, Feridex IV® for liver and spleen imaging
and Combidex® for lymph node metastases imaging.24
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1.3.3 Hyperthermia
SPIONs are used in the hyperthermic treatment of tumors. The exposure of
SPIONs to alternating magnetic fields induces oscillation of magnetic moment in
the particles; magnetic field energy is transformed into heat and liberated into
tissue environment. This heating at high temperature (42 – 46 ºC) causes
irreversible damage to tumor cells as opposed to reversible damage of healthy
cells. Hence, hyperthermia is very useful cancer treatment. Microwaves,
ultrasound, infrared and radiofrequency were successfully used conventionally
for hyperthermia treatment. However, these techniques lack selectivity and could
not induce heat in a specific tissue and temperature distribution is
inhomogeneous. SPIONs, due to their smaller size, are absorbed into cells at a
higher rate and homogenously distributed in the tissue.

1.3.4 Biological molecule separations
Magnetic properties of the magnetic nanoparticles in the presence of external
magnetic field made them as attractive tools for bioseparations.25-28 Magnetic
nanoparticles

have

been

widely

used

in

purification

processes

and

immunoassays. Magnetic micro and nanoparticles were used for effective
immobilization and separation of several biomolecules.29,

30

Due to their small

size, magnetic nanoparticles can be effectively used as “mobile substrates” in
bio-assays. They can also be conveniently incorporated into micro and
nanofluidic devices.25 Magnetic particle based biosensors are widely used for
detection of small quantities of biomarkers in clinical diagnostics.31 Magnetic
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particles are coupled to antibody or aptamer for target binding. They provide
efficient target capture and convenient separation. Magnetic field flow
fractionation(MFFF) and electrical field flow fractionation (ElFFF) have been used
for separation of variable size magnetic nanoparticles.32 Wang et al. showed the
use of superparamagnetic microspheres in affinity adsorption of glutathione, a
tripeptide found in mammals.33

Magnetic particles help in pre-concentration and effective separation of analytes.
They also offer advantages over filtration, centrifugation and solid-phase
extraction. Processes using magnetic particles are less tedious and less time
consuming. Magnetic micro and nanoparticles with high surface area account for
minimum steric hindrance, effective surface reaction efficiencies and improved
capture efficiency. Magnetic separation is simple and involves application of high
magnetic field strength to separate the magnetic particles from its carrier
solution. However, time required for magnetic separation depends upon the size
and stability of magnetic nanoparticles in solution as well as strength of the
applied magnetic field.

Okamoto et al. reported the use of magnetic microspheres for online
preconcentration and selective separation of lipoproteins by affinity CE.34 In this
work, multifunctional magnetic microspheres (MFMPs) with a coating of cationic
fluorescent tag and anionic affinity ligands on the surface are used. MFMPs are
mixed with sample analyte and injected into the capillary as a plug. Online

Chapter 1

11

trapping and preconcentration of analytes is achieved by applying a magnetic
field on the capillary. On removing the magnetic field, the analytes move towards
the detector window and detected by laser induced fluorescence (LIF) detector.
The concept of online preconcentration and selective separation using MFMPs is
shown in figure 1-3.
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Figure 1-3: Schematic of online preconcentration and selective separation of
lipoproteins using multifunctional magnetic particles (MFMPs) in affinity CE
(adapted from reference 28).
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Magnetic micro and nanoparticles due to their high surface area enhance the
specific interaction of affinity ligands (coated on their surface) with their targets,
thus, helping in analyzing trace amounts of analytes. In my research work, I
demonstrated the use of SPIONs as analytical sensing elements. I have also
made a comparison between the efficiency of magnetic microspheres and
nanoparticles.

1.4 Objectives of my research:
My research mainly focuses on synthesis of monodisperse SPIONs, surface
coating of SPIONs with biocompatible polymers, and attaching biomolecules.
These SPIONs are characterized using various analytical techniques such as
transmission electron microscope (TEM), Fourier transform infrared spectroscopy
(FTIR), Dynamic light scattering (DLS), x-ray diffraction (XRD) and UV-Visible
spectroscopy (UV-Vis). SPIONs are also demonstrated as excellent capture
elements/ immobilization tools for analytical separations.
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Chapter 2
Pluronic triblock copolymer-modified mono disperse Superparamagnetic Iron
Oxide Nanoparticles (SPIONs)
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2.1 Introduction
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) are extensively being studied
for cancer therapy due to their use in targeted drug delivery, contrast enhancement in
Magnetic Resonance Imaging (MRI) and hyperthermia for localized cell death.1, 2 In the
last two decades, the use of magnetic nanoparticles in biomedical applications has
increased significantly especially in the treatment of cancer through tumor targeting.3, 4

Successful use of nanoparticles in biomedical applications is highly dependent on the
stability of these particles under in-vivo conditions. The ability to stabilize and disperse
the nanoparticles in an aqueous environment and modify the surface with molecules,
proteins or other targeting agents is a crucial step for biomedical applications and
bioanalysis.1,

5

Magnetic nanoparticle mediated drug delivery potentially reduces the

drug dose, while improving drug efficiency. These effects are due to the poor lymphatic
drainage of the cancer cells resulting in enhanced permeability and a retention affect of
nanoparticles at the tumor site (also known as passive targeting).6 Surface modification
of the nanoparticles with polymers helps to avoid uptake by the reticulo-endothelial
system and mononuclear phagocytes7 and provides long circulation times of
nanoparticles. Apart from drug delivery, magnetic nanoparticles can also be used for
simultaneous Magnetic Resonance Imaging and hyperthermia treatment of cancer
cells.2, 8
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Although there are different methods of synthesizing SPIONs9,

10

, the chemical co-

precipitation method using iron salts is the most commonly employed methodology.11
However, this method often produces polydisperse materials.11 In this study, thermal
decomposition of iron pentacarbonyl in the presence of oleic acid as a surfactant was
used to synthesize uniform, monodispersed and unaggregated SPIONs to facilitate our
study of the effects of polymer modification with the exclusion of structural variation. The
particles as-synthesized are hydrophobic, and were modified by adsorption of Pluronic
triblock copolymers to facilitate aqueous dispersion and stability. A number of methods
have been described in the literature for surface modification of similar SPIONs for
targeted drug delivery.12, 13

Amphiphilic Pluronic tri-block copolymers are approved by FDA for use in humans and
are currently being used as a part of drug and gene delivery systems.14-16 Commercially
available, Pluronic tri-block co-polymers were used here to provide water solubility and
prevent aggregation and simultaneously create a hydrophobic region within each
SPION-Pluronic conjugate which is capable of holding hydrophobic drug molecules.
Pluronics are triblock co-polymer surfactants (PEO-PPO-PEO) with hydrophobic
polypropylene oxide (PPO) units sandwiched between hydrophilic polyethylene oxide
(PEO) chains. The composition of the Pluronic dictates the surfactant HydrophilicLipophilic Balance (HLB). The HLB value of a surfactant is a semi-empirical measure of
the degree to which it is hydrophilic or lipophilic based on emulsification behavior, with
higher HLB indicating greater hydrophilic nature. For Pluronics, the relative size of
different regions (PEO and PPO) of the copolymer affects the HLB value and a greater
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number of ethylene oxide (EO) units in the Pluronic, yields a higher HLB value. A block
diagram of a Pluronic structure is given in Figure 2-1 and a summary of the Pluronics
used in this experiment is given below in Table 2-1.
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Figure 2-1: Pluronic Block Diagram showing the hydrophobic polypropylene oxide
units(PPO) sandwiched between hydrophilic polyethylene oxide units (PEO)

Table 2-1: Summary of Pluronic polymers studied in this work
Type of

Molecular

# of PPO

# of PEO

Pluronic

weight

Units[Y]

Units[2X]

P 123

5750

69

P 85

4600

F 127
F 108
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HLB Value

CMC[M]

38

7 – 12

4.4 X 10-6

40

52

12 – 18

6.5 X 10-5

12600

65

200

18 – 23

2.8 X 10-6

14600

50

264

>24

2.2 X 10-5
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Although Pluronic-coated SPIONs have been studied by Jain and co-workers,8, 17, 18 the
SPIONs used were produced by co-precipitation; thus phase transfer is not an issue as
the synthesis and modification of SPIONs with polymers both occur in aqueous phase.
This could cause variability in SPION stability since the surface of the SPION is
hydrophilic and could be expected to interact with the Pluronic differently. Other
methods have also been proposed for the phase transfer of SPIONs from organic to
aqueous phases19-21 which typically resulted in low concentrations of material and there
for requiring excessive processing times.

The method described herein is a technically simpler and faster approach of phase
transfer for the production of water soluble SPIONs. This approach was used with the
selected Pluronics, which covered a wide range of molecular weights and HLB values,
to specifically study the physical structure-property relationships in SPIONs. By using
the same SPION core throughout this work, the described experiments probed the
effect of the Pluronic on the hydrodynamic size of the SPION-Pluronic conjugate and
the potential impact on drug delivery. A drug model, the fluorescent dye 1,1’dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate (DiI) (chemical structure
shown in figure 2-2) was used for determining drug loading capacity, the results of
which are reported here. The schematic of dye loaded Pluronic-OA-SPIONs is shown in
figure 2-3.
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Figure 2-2: Structure of 1,1’-dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine per
chlorate (DiI), chemical formula: C59H89ClN2O4, molecular weight : 924.5g/mol

OA-SPIONs that were surface coated pluronic were made by a simple and efficient
method. Both OA-SPIONs and pluronic-OA-SPIONs were characterized by various
analytical techniques so as to evaluate the role of PEO and PPO units of Pluronic
polymers on hydrodynamic size and stability. Furthermore, the mechanism of
polymer assembly on the SPION surface based on the properties of different
Pluronics is hypothesized.

Chapter 2

26

Chapter 2

27

Figure 2-3: Schematic representation of DiI dye loaded Pluronic-OA-SPIONs synthesis

2.2 Experimental
2.2.1 Materials and Methods
2.2.1.1 Reagents and materials
All chemicals including Iron pentacarbonyl, Oleic acid, Trimethylamine N-oxide and 1-1’dioctadecyl-3,3,3’3’-tetramethylindocarbocyanine perchlorate (Dil) –were purchased
from Sigma Aldrich (St.Louis, MO, USA). Solvents including toluene, hexane and
ethanol were obtained from Fisher Scientific (Pittsburgh, PA, USA). Pluronic samples
were obtained as gift from BASF chemical company (Florham Park, NJ, USA).

2.2.1.2

Synthesis

of

monodisperse

magnetic

nanoparticles

by

thermal

decomposition
The nanoparticles were synthesized by thermal decomposition method as previously
described.

9

A solution of Oleic acid (5.12 g, 18.1 mmol) in octyl ether (40 mL) was

heated at 100oC Fe (CO)5 (0.8 mL, 5.93 mmol) added the mixture then heated at reflux
for 1 h and then cooled to room temperature. Solid anhydrous trimethylamine N-oxide
(1.36 g, 18.1 mmol) was then added and the mixture heated at 130 0C for 2 h (the
reaction mixture becomes brown).

The mixture was then heated at reflux for an

additional hour (becomes black in appearance). Cooled to room temperature, ethanol
added to remove the excess oleic acid, and then this mixture was dispersed in toluene
by stirring. The purified SPIONs were easily dispersed in toluene at a concentration of 6
mg/mL.
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2.2.1.3 Preparation of Pluronic coated OA-SPIONs
Oleic acid-coated SPIONs (12 mg) in toluene (2 mL) were added to a Pluronic(48 mg)
dissolved in distilled water (8 mL), cooled to 0 ºC and subjected to horn ultrasonication
for 30 min. The ultrasonication resulted in an emulsion of toluene in water containing
Pluronic-coated SPIONs. The emulsion was broken using ultracentrifugation at 14,000
rpm for 15 min. The aqueous layer turned brown in color, indicating the presence of the
Pluronic-coated SPIONs that were carefully separated from the toluene using a syringe.
Excess Pluronic in these samples was removed using centrifuge filters with a 100 kDa
molecular weight cut-off at 2,000 rpm for 15 min. This purification was repeated three
times to ensure the samples were free of excess Pluronic. Pluronic-coated SPIONs
were redispersed in deionized water (picture of solutions shown in figure 2-4). These
samples were then lyophilized for 24 h to produce dry powders.
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Figure 2-4. From left to right: Water, P 123 coated SPIONs, P 85 coated SPIONs, F
127 coated SPIONs, F 108 coated SPIONs, oleic acid coated SPIONs. All pluronicSPIONs as aqueous dispersions at the same concentration; oleic acid-SPIONs in
toluene.

2.2.1.4 Loading of DiI dye onto Pluronic coated SPIONs
The

carbocyanine

dye,

1,1'-dioctadecyl-3,3,3'3'-tetramethylindocarbocyanine

perchlorate (DiI) is a water-insoluble dye used as a drug analogue in our study. A stock
solution of 0.2 mg/mL in DMF was used for all experiments. To the 1.5 mL of 1mg/mL
Pluronic coated SPIONs samples, 0.5 ml of 0.2 mg/mL DiI dye in DMF was added and
stirred for 48 h. During this time, the dye molecules partition into the hydrophobic region
of the Pluronic-SPIONs defined by the oleic acid and PPO region of the pluronics. The
amount of drug entrapped by each SPION is proportional to the hydrophobic region of
the particle. After 48 h, the dye-loaded Pluronic-SPIONs were separated from the dye
solution using a strong magnet and resuspended in deionized water. Dye-loaded
Pluronic-SPIONs dispersed in water were then analysed by absorption spectroscopy at
λabs = 549 nm. Drug entrapment efficiency of the four different Pluronic coated SPIONs
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was calculated using a calibration curve. Entrapment efficiency is given as a ratio of
drug/dye loaded onto SPIONs to the total drug/dye used.

2.2.2 Characterization
Transmission Electron Microscopy : The morphology and size of the SPIONs was
characterized by TEM (JEOL-JEM-2100) operating at an accelerating voltage of 80 kV.
A drop of the nanoparticle sample was placed on a carbon coated 200 mesh Cu grid
sample holder, followed by drying the sample at room temperature.
X-Ray Diffraction: A SPION sample was characterised by room temperature XRD.
Diffraction patterns were collected with a Rigaku diffractometer using CuKα radiation
(λ=0.154185nm) in the scanning range of 2θ = 150 to 1000.
Dynamic Light Scattering:

Measurements were recorded using a Zetasizer Nano

(Malvern UK) at a detection angle of 173

0

with a 3 mW He-Ne laser operating at 633

nm. DLS was used to measure the hydrodynamic diameter of the SPIONs dispersed in
toluene and Pluronic coated SPIONs of each kind dispersed in water at 25 0C.
Fourier Transform Infrared Spectroscopy: FTIR Spectroscopy was used to verify
functional group modification of SPIONs after synthesis and modification with pluronics.
Spectra were collected on samples that were dried on ATR sampling accessory of FTIR
(Perkin Elmer) and the percent transmittance spectrum was taken over a range of 4000650 cm-1 .

Chapter 2

31

Thermogravimetric Analysis: Therrmogravimetry of the SPIONs and Pluronic coated
SPIONs was studied by using TGA 7 (Perkin Elmer) . Samples were heated to 800 ºC in
a stream of Argon gas (20 ml/min) at a rate of 20 ºC/min and were held at 800 ⁰C for 30
min.
Absorption Spectroscopy: Absorption spectra of the dye loaded Pluronic coated
SPIONs were obtained using Cary 50 UV-Visible Spectrophotometer. The spectra were
recorded from 300 to 800 nm.

2.3 Results and Discussion
2.3.1 Particle Size
As previously reported by others22, the SPIONs prepared by thermal decomposition
were well dispersed and monodisperse with an average particle size of 10.1 ± 0.9 nm
(Figure 2-5a).

The size distribution was determined by algorithmic analysis of

measurements taken for ~500 nanoparticles using Image J. SPIONs synthesized by
thermal decomposition are highly crystalline as evidenced by HRTEM images shown in
inset of Figure 2-5a. Lattice planes are clearly visible and the lattice spacing is
consistent with the <206> plane of γ-Fe2O3, maghemite. From DLS, the hydrodynamic
size of the oleic acid-coated SPIONs (OA-SPIONs) is found to be approximately 11.8 ±
0.1 nm. This size is consistent with that determined by TEM, given that TEM neglects
the presence of the oleic acid surfactant, and the DLS measurement includes
interactions between surfactant and associated solvent molecules.
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A TEM image of Pluronic coated SPIONs is shown in Figure 2-5c and no observable
change in crystallinity was observed. An increase in the distances between particles
(corresponding to a larger surfactant layer) was not observed between the OA-SPIONs
and Pluronic coated nanoparticles. This is because, it is hard to see the organic polymer
coating clearly with TEM. However, we could see the formation of cluster like structures
with the Pluronic coated SPIONs on the carbon grid indicating the phase transfer of
SPIONs. The formvar coated Cu grid used for the TEM sample preparation is
hydrophobic and since the OA-SPIONs in toluene are coated with Pluronics and
transferred to aqueous phase, the particles are not spread out uniformly on the grid.
That is why the TEM image of Pluronic coated SPIONs were seen as clusters rather
than single particles. However, DLS results (Figure 2-8) support that the Pluronic coated
SPIONs are not aggregating and are stable.
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Figure 2-5. a) TEM image of OA-SPIONs in toluene; inset shows HRTEM image of
OA-SPIONs showing crystal lattice b) Size distribution of OA-SPIONs by image J
c) TEM image of Pluronic-OA-SPIONs
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In figure 2-6, the XRD pattern of the iron oxide nanoparticles is shown. XRD was
performed to determine the crystal lattice parameters of the magnetic nanoparticles.
XRD analysis indicates that the synthesized particles were γ-Fe2O3 (Maghemite) based
on the positions of peaks. XRD peak analysis and fitting to the Scherrer equation gave a
crystallite size of 10.5 nm in close agreement with TEM and DLS results.
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Figure 2-6. XRD patterns of oleic acid coated SPIONs synthesised by thermal
decomposition with standard diffraction pattern for maghemite shown by the vertical
lines.
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2.3.2 Pluronic adsorbed on SPIONs
The preparation technique described here takes advantage of the tendency of the
Pluronic block copolymers to adsorb to hydrophobic surfaces through the central PPO
block, with the PEO blocks projecting away from the surface. This phenomenon has
been extensively studied with respect to Pluronic adsorption on flat surfaces, particles
and vesicles.23-26 Here, the adsorption of the Pluronics to the hydrophobic OA-SPIONs
imparts aqueous solubility to the SPIONs, and increases the volume of hydrophobic
materials at the SPION surface into which hydrophobic drug molecules will selectively
partition.

Excess Pluronic molecules were removed from the Pluronic SPIONs

suspension through the use of centrifuge filters with a molecular weight cutoff of 100
kDa. This is much higher than the molecular weight of even the largest of the Pluronics,
and empirical examination showed no passage of Pluronic-SPIONs through the filter. To
confirm that the Pluronics were adsorbed onto the SPIONs, the OA-SPIONs and
Pluronic-SPIONs were analyzed by FTIR, DLS and TGA.
The FTIR spectra of OA-SPIONs, Pluronic and Pluronic-OA-SPIONs are shown in
Figure 2-7. The OA-SPIONs show strong peaks corresponding to methyl/ethylene
symmetric/asymmetric stretches at 2750-3000 cm-1 along with carboxylate anion
stretches at 1467 cm-1 and 1526 cm-1, confirming the presence of oleic acid on the
synthesized particles. After Pluronics were adsorbed onto the exterior of the SPION,
the intensity of these peaks is attenuated by the coating of Pluronic co-polymer. All the
Pluronic-SPIONs show spectra consistent with free Pluronic in solution shown as a
reference confirming the adsorption of pluronics onto SPIONs.
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Figure 2-7. FTIR spectra of OA-SPIONs, Pluronic-OA-SPIONs and free
pluronic F127 as reference showing the functional groups.

Chapter 2

38

Pluronics of various sizes were adsorbed to the OA-SPIONs. Two primary possibilities
exist for adsorption mechanisms of Pluronics to the hydrophobic OA-SPIONs: 1) the
PPO block interacts with the surface of the OA-SPIONs, or 2) the PPO block
interpenetrates the OA surfactant layer on the SPIONs. In either case, the adsorption of
the Pluronics onto the OA-SPIONs will be self-limiting due to the loss of conformational
entropy of the PEO (entropy associated with the compact physical arrangement of PEO
chains of polymer in solution).

From the DLS results (shown in figure 2-8), we can observe that with the increase in
molecular weight of the Pluronics and the PEO subunits, the hydrodynamic size of the
pluronic-SPIONs increases. However, we could see a discrepancy in the trend with P
123. Though P 123 has fewer PEO units, it has higher hydrodynamic size than F 127.
This might have been due to the formation of micelles. We observed almost similar
results with these systems when checked after 6 months for their stability over time.
This reveals that this novel method followed for the phase transfer of SPIONs results in
stable systems. This will be a great advantage in terms of the formulation shelf life in
future.
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Figure 2-8. a) Graphical Representation of hydrodynamic size variation of Pluronic
coated OA-SPIONs before b) after 6 months
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Thermo gravimetric analysis was used to understand the mass relationship between the
surfactant layer and iron oxide core of the particles allowing estimation of the surface
coverage for each system. All the Pluronic-coated SPION samples began losing mass
at 150 ºC and stabilized by ~500 ºC as seen in Figure 2-9 as determined from the first
derivative curves of TGA data. Oleic acid-coated SPIONs lost mass beginning ~220ºC.
Assuming that the Pluronic block co-polymer is desorbed from 200ºC to 500ºC, the
percent coating on the SPIONs was calculated and is shown in Table 2-2. From
consideration of the TGA data of the OA-SPIONs (Figure 2-9), oleic acid represents
22.6 % of the total coating in all the samples and the remaining percentage of coating is
the Pluronic. These results suggest that the P123 and F127 SPIONs are coated well
with the Pluronic followed by F108 and P85 in agreement with the DLS data.
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Figure 2-9. TGA of SPIONs and Pluronic coated SPIONs showing the degradation of
organic polymer at high temperatures

Table 2-3. Analysis of TGA results
Type of

Temperature

%wt.

Temperature

%wt.

% coating

Pluronic

(T1 in

remaining at

(T2 in

remaining

on

Celsius)

T1

Celsius)

at T2

SPIONs

OA-SPIONs

205.14

96.22

500.09

73.58

22.65

P85

205.46

82.16

500.60

47.28

34.87

P123

205.32

97.39

500.33

52.32

45.06

F127

205.40

93.58

500.41

47.27

46.31

F108

205.23

82.67

500.52

41.64

41.03
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Though P123 is the smaller molecule (MW 5750 AMU) the TGA results of P123SPIONs suggest that it behaves similar to that of F127-SPIONs i.e. it showed similar
surface coverage as that of F127. Both F127 and P123 have equivalent percent weights
of Pluronic coating as per the TGA analysis from Table 2-2. This can be attributed to
their similar number of PPO groups (69 in P123 and 65 in F 127) that helps in the
attachment of Pluronics to the SPIONs. As expected, P85 with fewest number of PPO
units and low molecular weight showed the smallest percentage of Pluronic coating on
SPIONs, which supporting the proposed role of PPO in the adsorption of pluronic onto
SPION. F108-SPIONs showed a higher percentage of Pluronic coating compared to
P85-SPIONs and lesser coating compared to P123 & F127-SPIONs also supporting the
role of PPO in the adsorption of Pluronic on SPION.

2.3.3 Loading of hydrophobic dye DiI onto Pluronic coated SPIONs
Absorption spectroscopy was used to determine the absorbance of dye encapsulated
by Pluronic-OA-SPIONs and all the samples showed a distinct absorption double peak
similar to that of standard solutions of dye (shown in Figure 2-10a). Since the λmax of the
dye adsorbed onto SPIONs has shifted, absorbance at 590 nm is taken both for
Pluronic-SPIONs and dye loaded Pluronic SPIONs. Here, we are assuming that the
molar absorptivity of the dye remains the same even on the nanoparticle surface, which
may not be true. Hence, the calculated values (based on background subtracted
absorbance) of loading efficiency can be slightly different. However, the qualitative trend
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shown remains the same. A calibration curve was derived from carbocyanine dye
solutions of known concentrations yielding a linear fit of y= mx +c. Percent entrapment
efficiency of the Pluronic coated SPIONs was calculated from the calibration curve.

% Entrapment or loading efficiency is given by:
(Dye loaded onto SPIONs (μg/mL) / Total dye used for loading (μg/mL)) *100
Refer to the sample calculation is given on pg. 66 in chapter 3.
The comparison of hydrophobic dye entrapment efficiency of OA-Pluronic SPIONs is
shown in Figure 2-10b. The drug encapsulation efficiency increased with the increase in
molecular weight and size. SPIONs coated with Pluronic F108 showed the highest dye
entrapment efficiency followed by the Pluronic F127. Thus the structural and molecular
size properties of the Pluronics on the SPIONs play a major role in the drug storage
capacity. The larger entrapments are attributed to larger hydrophobic regions being
created in the polymer layer as would be expected from system involving longer PPO
chains.
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Comparison of hydrophobic dye loading onto
Pluronic SPIONs
95.1

100.0
% loading efficiency

90.0

79.0

80.0
70.0

55.0

60.0
50.0
40.0
30.0

22.1

20.0
10.0
0.0
P85

P123

F127

F108

Figure 2-10. a) UV-Visible absorbance of OA-Pluronic SPIONs with entrapped DiI dye
b) Comparison of hydrophobic dye loading efficiency of OA-Pluronic SPIONs
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2.4 Conclusions & Future directions
A simple, novel and fast approach of coating Pluronics onto uniform monodisperse
SPIONs has been developed and has proved to be successful in producing potentially
biocompatible aqueous solutions of maghemite. This study on hydrodynamic diameter
variations and thermo gravimetric analysis of various Pluronic coated SPIONs clearly
indicated that the structure and molecular weight of Pluronics play a major role in the
attachment of these polymers onto SPIONs and also demonstrated their effect on drug
analogue entrapment efficiency based on the absorbance data.

These absorbance measurements and comparison of drug loading efficiencies can be
considered as qualitative or semi quantitative. Quantitative measurements can be
achieved by separating SPIONs from supernatant using ultracentrifugation and then
measuring the drug in both fractions. In this method, if the molar absorptivity (ε) of the
dye is affected by interaction with the SPION coating the absorbance can be
determined by the method of standard addition. If this is not feasible e.g. due to dye
saturation, then after separating the SPIONs from supernatant the dye can be released
in an organic solvent, recovered and reconstituted in a solvent equivalent to the
supernatant and measured with UV-Vis absorbance.

Pluronic F127 and F108 were found to be the most efficient of polymer coatings for
drug encapsulation studied here. The comparison of entrapment efficiency of these
Pluronic SPIONs will give an idea on how much of hydrophobic drug could be loaded.
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However, release and bioavailability of drug in the biological environments is more
important for its in vivo applications. Now that the entrapment efficiency of Pluronic
SPIONs is characterized, the next step towards the clinical development is to study the
drug release properties in-vitro from these systems produced by the new approach
described here.

Tri block co-polymers Pluronics are commercially available and are FDA approved.
Pluronic coated oleic acid-SPIONs can be used for loading hydrophobic drugs for
targeted drug delivery by passive targeting. However, Pluronic polymers lack a
functional group useful for conjugating biomolecules and cannot achieve active
targeting.
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Chapter 3
Antisense Survivin coupled surface modified magnetic nanoparticles for
targeted cancer therapy
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3.1 Introduction
In the previous chapter SPIONs were synthesized by thermal decomposition and
surface modified with tri-block co-polymers, Pluronics. To these surface modified
SPIONs, a hydrophobic dye was loaded as a surrogate to drug.

However,

Pluronics lack the functional groups necessary to attach the biomolecules such
as antibodies and nucleic acids that may help in active targeting for drug delivery
as well as magnetic resonance imaging. Hence, this chapter demonstrates the
possibility of using a co-polymer with a functional group useful for attaching
nucleic acid ligands onto SPIONs. An anti cancer drug, epirubicin was also
loaded onto these functionalized SPIONs.

Nanoparticles possess distinct physical and chemical properties which make
them unique for many applications such as biosensing, drug delivery and
separations.1-5 Magnetic nanoparticles in particular offer several advantages.
Superparamagnetic iron oxide nanoparticles (SPIONs) have been demonstrated
to be biocompatible with living systems. Hence SPIONs are under investigation
for use in a wide range of human health applications, including targeted drug
delivery, MRI contrast enhancement and hyperthermia.6-8 To achieve these
goals, control of particle structure, function, and stability in physiologically
relevant conditions is critical.9
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Currently a number of SPIONs based therapeutics are under investigation,
examples include Lumiren® for bowel imaging, Feridex IV® for liver and spleen
imaging, Combidex® for lymph node metastases imaging, and Ferumoxytol ® for
iron replacement therapy.10 However, these SPIONs lack multifunctional
properties such as specific targeting of drug delivery or imaging. Though the
passive targeting of nanoparticles is possible for using them in cancer therapy, it
is neither homogenous in all tissues nor effective in all types of cancer. To
overcome this limitation, use of active targeting by functionalizing nanoparticles
with different biomolecules is proposed.

DNA sequences that interfere with protein expression (Antisense DNA) are
effective in treatment of cancer.11-13 Survivin, a protein over expressed in many
cancer types, inhibits apoptosis which allows cancer cells to grow unchecked.
Survivin has also been shown to be one of the most cancer-specific proteins
identified to date, being up-regulated in almost all human tumors. It is known to
have roles in the apoptosis (programmed cell-death) pathway, enhancing cell
proliferation, and promoting angiogenesis, the development of new blood
vessels14,

15

. The use of antisense DNA in therapies targeted at reducing the

expression of survivin may be effective in treating cancer. Recent results have
shown that antisense DNA coupled to nanoparticles has an increased
effectiveness compared to unconjugated DNA.
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The goal of this work was to develop a stable, highly effective SPION-based
platform which can be targeted to specific cell types and serve as a vehicle for
therapeutic drug delivery all the whole providing enhanced imaging contrast. The
central hypothesis is that functionally modified SPIONs will preferentially target
cancerous cells and thereby effectively delivering therapeutically significant
concentrations of anti-tumor drugs. Three specific aims further explain the overall
objective of this work: 1) identify design parameters for SPIONs that optimize
aqueous stability and maximize amphiphilic character, 2) evaluate drug storage
characteristics of SPIONs, and 3) demonstrate binding of antisense survivin DNA
to SPIONs. Here, the amphiphilic shell coating the SPION core was
functionalized with a targeting ligand. This targeting mechanism was then tested
in A549 cancer cells, which overexpress the apoptosis inhibitory protein,
Survivin. Targeting the Survivin mRNA sequence has been shown an effective
antisense target suppresses survivin production and is used as the basis for
SPION specificity.15 The antisense oligonucleotide sequence (aSL) used was:
5’

CCCAGCCTTCCAGCTCCTTG-(CH2)6-3’NH2. This oligonucleotide sequence

was coupled to the biocompatible SPION and the reaction conditions for this
process were optimized. Coupling of oligonucleotide to SPION is measured by
spectroscopic techniques.

In this work, we focus on drug loading and molecular targeting for drug delivery.
Epirubicin is a potent anticancer drug, but systemic dosing causes undesired
side effects, including immune system suppression, since epirubicin affects
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healthy cells as well as cancer cells.16 Specific targeting of epirubicin release to
cancer cells can increase the bioavailability of drug while reducing side effects to
the patient. Here we report the loading of fluorescent anticancer drug Epirubicin
(figure 3-1) onto modified SPIONs and the conjugation to tumor targeting
antisense Survivin DNA.

O

OH

O
OH

CH3

O

O

HO

OH

OH

O

NH2

Figure 3-1: Chemical structure of Epirubicin
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Figure 3-2: Schematic depicting the construction of Antisense Survivin DNA coupled magnetic nanoparticles

3.2 Experimental
3.2.1 Materials and methods
Epirubicin (EPI) in the form of the hydrochloride salt was purchased from SigmaAldrich. EPI base was prepared by mixing EPI with three equivalents of
triethylamine (TEA) in dimethylformamide. Phosphate buffer saline (PBS) was 10
mM sodium monobasic phosphate, 2 mM potassium dibasic phosphate
containing 137 mM sodium chloride and 2.7 mM potassium chloride, pH 7.4. All
chemicals including Iron pentacarbolyl, Oleic acid, Trimethylamine N-oxide were
purchased from Sigma Aldrich (St.Louis, MO, USA). All the solvents which
include DMF, triethylamine, toluene, hexane and ethanol are obtained from
Fisher Scientific (Pittsburgh, PA, USA).

All reactions were conducted under an inert nitrogen atmosphere unless
otherwise noted. For oligo synthesis: phosphoramidite DNA bases, fluorophore
phosphoramidites and CPG columns were obtained from Glen Research
(Sterling, VA). Oligonucleotides were prepared on an ABI 391 DNA synthesizer
using standard coupling conditions except for the fluorophore phosphoramidite
for which 3 min coupling time was used. The antisense survivin ligand (aSL)
oligonucleotide was prepared without and with a fluorophore (f-aSL). In the case
of f-aSL, the fluorophore was located on the 5’-terminus and added during
synthesis.
5’

The

sequences

of

the

oligonucleotides

prepared

were

CCCAGCCTTCCAGCTCCTTG-(CH2)6-3’NH2 (aSL) and reverse complement
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5’

CAAGGAGCTGGAAGGCTGGG3 (aCS) with the 5’-trityl group removed at the

end of the synthesis.

3.2.2 Synthesis and characterization of OA-SPIONs
The oleic acid SPIONs (OA-SPIONs) were synthesized by a thermal
decomposition method. The OA-SPIONs were well characterized by various
analytical techniques such as transmission electron microscopy (TEM), dynamic
light scattering (DLS), fourier transform infrared spectroscopy (FTIR) and thermo
gravimetric analysis (TGA). The synthesis and characterization of OA-SPIONs
are described in detail in Chapter 2. The same batch of SPIONs was used here
in this work for surface modification using a different polymer with a functional
group: 40% octylamine modified polyacrylic acid.

3.2.3 Surface modification of SPIONs by modified polyacrylic acid
Modified polyacrylic acid (PAA) has been previously used as a coating for the
quantum dots for phase transfer and achieved a good yield.17,

18

Briefly, 1800

molecular weight polyacrylic acid powder(2.5 g, 1.39 mmol) was diluted in dry
N,N-dimethylformamide (35 mL) and EDC-HCl (2.66 g, 13.9 mmol) was
dissolved. The solution was stirred for 30min followed by the addition of
octylamine (2.3 mL, 13.9 mmol). The solution was stirred at room temperature
overnight. Deionised water was added to precipitate the polymer which was
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isolated by centrifugation. Excess water was discarded. An aqueous solution of
1M NaOH was added and solution was shaken overnight to resolubilize the
polymer in water. Crude modified solution obtained was washed by ethyl acetate
to improve the clarity of aqueous polymer suspension. The polymer was reprecipitated by adding dilute HCl to adjust the pH to 5. Solid product was
collected by centrifugation and dried under vacuum. The final product was
carefully neutralized using 0.1M NaOH solution and lyophilized for storage. This
gives 40% octylamine modified PAA polymer which will be referred to as
modified PAA copolymer.

OA-SPIONs were coated with the modified PAA copolymer by mixing solutions of
each in miscible solvents (toluene and chloroform respectively). The solvents
were evaporated by vacuum centrifugation and the PAA-OA-SPIONs were
redissolved or resuspended in DI water at basic pH ~8 by sonication for 2hrs at
room temperature.

3.2.4 Oligonucleotide Synthesis and purification
Oligonucleotides were prepared on a 1 μmol scale using an ABI-394 DNA and
RNA Synthesizer using the standard coupling cycle and times.

All

oligonucleotides bore a 3’ amino linker (6 carbon) so that they could be coupled
to the SPIONs.

The aSL oligonucleotide was prepare without and with a

fluorophore (f-aSL), In the case of f-aSL, the fluorophore located on the 5’Chapter 3
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terminus and added during synthesis. The sequences of the oligonucleotides
prepared
5’

were

5’

CCCAGCCTTCCAGCTCCTTG-(CH2)6-3’NH2

(aSL)

and

CAAGGAGCTGGAAGGCTGGG3 (aCS) with the 5’-trityl group removed at the

end of the synthesis. Oligonucleotides were cleaved off the resin by treatment
with concentrated NH4OH (28-30%, 1 ml) at room temperature for 1 hour and
filtered through 0.2 μm filter disk.

The cleavage of protecting groups was

accomplished by heating the filtrate at 55oC for 20 h and then dried down in a
SpeedVac. Final purification of oligomers was achieved by (FPLC) using a BioRad TSK DEAE-5-PW column. Both oligonucleotides were purified using a linear
gradient (10-70% B over 60 min, Buffer A: 10 mM NaOH, pH 11.8, Buffer B: 10
mM NaOH, 1 mM NaCl, pH 11.8, flow rate 7 ml/min, UV detection, 260 nm). The
oligomers were desalted with reverse phase Waters Sep-Pack (C-18) cartridges
by 60% MeOH/water elution.

3.2.5 Coupling of antisense Survivin to SPIONs
Conditions required for coupling of DNA were optimized. SPIONs (1 mg) in water
were treated with EDC in solvent for 30 min and then an aqueous solution of the
aSL oligonucleotide (1.5 mg) was added and the mixture allowed to react for 3 h
at 50oC, with constant shaking. Excess DNA was removed from solution by
filtration through a Vivaspin 100 kDa Molecular Weight Cut-off Filter (10 min, 250
x g) washing three times with water.
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3.3 Results & Discussion
In our work, to transform the hydrophobic oleic acid-SPIONs to water soluble
nanoparticles for biological applications we used an octylamine polyacrylic acid
co-polymer to assist in phase transfer process as well as a means for coupling
the targeting biomolecules for targeted drug delivery.

An amphiphilic copolymer was prepared by coupling of octylamine to polyacrylic
acid (PAA) backbone using EDC catalyzed coupling. Octylamine was coupled to
approximately 40% of available carboxylic acid groups on PAA. This amphiphilic
copolymer imparted aqueous stability to the SPIONs and provided coupling sites
for attachment of targeting molecules. Copolymer structure was assessed by
ATR-FTIR and dynamic light scattering.

3.3.1 Fourier Transform Infrared Spectroscopy
In figure 3-4, the prominent peaks at 2750-3000 cm-1 correspond to
symmetric/asymmetric stretching mode of the methyl/methylene units in both
oleic acid and the PAA-copolymer. The sharp peak at 1710 cm-1 in OA-SPIONs
is the C=O stretch of oleic acid – the same region is broadened in the PAA-OASPIONs due to the increased number of acids on the PAA-copolymer. The
presence of peak at 1630 cm-1 is attributed to the amide C=O stretch from the
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octylamine-modified polymer. These peaks assignments are in accordance with
literature assignments.19
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A

B

A
B

Figure 3-3: FTIR spectra of A) SPIONs (black trace) and B) modified PAA
coated SPIONs (red trace)
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3.3.2 Dynamic Light Scattering of PAA-OA-SPIONs
The size and stability of modified PAA-OA-SPIONs in PBS (pH ~ 7.4) was
studied by DLS and the average hydrodynamic radius found by intensity size
distribution is 33 nm. The zeta potential of these particles was found to be - 82
mV. At pH 7.4, the carboxylic acid groups on the PAA-OA-SPION surface should
be largely deprotonated, providing a high stabilizing surface charge. This is
supported by the zeta potential measured.

3.3.3 Loading of Epirubicin onto PAA-OA-SPIONs
The Epirubicin (EPI) is a water-insoluble anticancer drug used for our study. A
stock solution EPI (0.5 mg/mL) in DMF was used for loading and making
standards. To the 3.6mL of 1mg/mL PAA coated SPIONs samples in water,
0.4mL of 0.5 mg/mL EPI in DMF was added and stirred for 48 h. During this time,
the drug molecules partitions into the hydrophobic region of the surface modified
SPIONs. After 48 h, the drug-loaded PAA-SPIONs were separated from the drug
solution using a strong magnet, supernatant drug solution was discarded and
PAA-SPIONs were resuspended in deionised water. This process is repeated
twice to ensure the removal of unadsorbed drug.

The amount of Epirubicin loaded into the SPIONs by the solvent diffusion
method, after stirring it overnight was determined by using the drug absorbance
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in absorption spectroscopy at 485 nm wavelength. This first requires the
preparation of a calibration curve and then measurement of the visible
absorbance of the SPIONs in the absence and presence of Epirubicin (Figure 35). The ability of the SPIONs to entrap a drug is quantified by calculating the
entrapment efficiency of the PAA coated SPIONs which is calculated using a
calibration curve. This may be lesser than the actual loading efficiency of these
systems since there might be change in molar absorptivity of dye on SPIONs.
Calculations:
Relative absorbance of EPI loaded SPIONs (obtained by subtracting absorbance
of polymer-SPIONs from absorbance of EPI loaded polymer SPIONs) = 0.293
EPI concentration loaded onto PAA-SPIONs (obtained from calibration plot)
= 29 μg/mL
Actual concentration of EPI used for loading = 50 μg/mL
% loading efficiency (or) entrapment efficiency is given by:
(Drug loaded onto SPIONs / Total drug used for loading) *100
% loading efficiency = (29 μg/L / 50 μg/mL) *100 = 58 %
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Figure 3-4. UV-Visible Spectroscopy of Epirubicin showing the spectra of
standards ranging from 10 μg/mL to 80 μg/mL EPI with overlaid traces of EPI
loaded PAA-OA-SPIONs and PAA-OA-SPIONs without drug.
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3.3.4 Coupling of fluorescent antisense survivin ligand (f-aSL) to SPIONs
Fluorescence

was

measured

using

a

Shimadzu

RF-5301PC

spectrofluorophotometer in emission mode, with a scanning range from 300-600
nm. Fluorometric analysis of f-aSL alone and after coupling to the SPIONs was
determined in water with λEx = 494 nm and λEm = 521 nm. Figures 3-5 shows
results measured by fluorescence studies of fluorescein modified antisense
Survivin oligonucleotides in solution as well as when coupled to SPIONs. Table
3-1 shows the emission intensity of all the samples and the concentration of faSL on SPIONs calculated from the calibration curve. Coupling of survivin to
SPIONs and its characterization was conducted by Dr. Gannett’s group at health
sciences. This data was obtained by Anand Narayanan from Dr. Gannett’s group.

Concentration
(ng/μL)

Emission @ 521nm

SPION f-asL36
SPION f-asL 17
SPION f-asL 8.6
SPION f-asL 4.9
f-aSL 28
f-aSL14
f-aSL 7.0
f-aSL 1.4

798
332
141
50
646
212
85
9

Table 3-1: Data obtained from fluorescence spectroscopy showing the
concentration dependence of samples and their emission intensity at 521 nm.
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Figure 3-5: Emission spectra of f-aSL and SPIONs f-aSL at various
concentrations. Emission peak is at 521 nm.

In this figure concentrations associated with SPIONs are calculated from the
calibration curve of f-asL. The slope and intercept obtained from linear regression
are 24 ± 3 (μL/ng) and 70 ± 47.
Based on fluorescence data obtained, number of f-aSL per SPION was
calculated assuming that the quantum yield remains the same for fluorescein
even after tagging to DNA and attaching to SPION. Each SPION was expected
to hold about 5 f-aSL molecules as per the calculated fluorescein molecules per
SPION.
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Calculations:
SPION density

5.24 g/cm^3

SPION radius

5.01 nm

Volume of SPION

523 nm3

Mass of SPION

2.74E-18 g/particle

Mass of SPIONs in 10mg sample
of OA - SPIONs as per TGA
# of SPIONs

Sample

0.00775 mg
2.82E+15

Emission
@521nm Conc (ng/uL)

Molarity

moles

x=
Conc (g/L) /
(y+69.59)/24.38 332.31(g/mol) M * V (L)

Calculation

molecules # of f - asL
of f-aSL
molecules per np
moles * A

f - asL molecules
/ # of SPIONs

7.36 μg
SPION:faSL

798

35.6

0.0001071

2.14E-08

1.29E+16

4.30

3.68 μg
SPION:faSL

332

16.5

4.955E-05

9.91E-09

5.97E+15

2.11

1.84 μg
SPION:faSL

141

8.6

2.596E-05

5.19E-09

3.13E+15

1.11

0.92 μg
SPION:faSL

50

4.9

1.473E-05

2.95E-09

1.77E+15

0.63

Molecular weight of fluorescein = 332.31 g/mol
Avogadro number (A) = 6.023 * 10^23
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3.4 Conclusions & future directions
SPIONs were surface modified with a biocompatible polymer: octylamine
modified polyacrylic acid. Aqueous solutions of surface modified SPIONs are
amenable to moderate scale-up due to the simple synthesis. An anticancer drug
Epirubicin

is

loaded

efficiently

and

quantified

by

visible

absorbance

measurement. However, the bioavailability of the drug released from SPIONs
should be further studied by in vitro drug release studies. The presence of
functional groups on the polymer made the coupling of DNA possible. The
coupling of antisense survivin DNA to PAA-OA-SPIONs using EDC-coupling
successful and was verified by spectroscopic techniques. The coupling of
oligonucleotide survivin to modified SPIONs will likely lead to active targeting of
drug loaden SPIONs selectively to cancer cells. This targeting mechanism is
being tested in A549 cancer cells, which over express Survivin.
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Chapter 4
Superparamagnetic Iron Oxide Nanoparticles (SPIONs) as a support for
analytical sensing
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4.1 Introduction

Nanoparticles are widely being used in various fields such as drug delivery,
imaging, labeling, sensing, analytical and bio-separations.1-3 Surface modification
of

nanoparticles

facilitates

conjugation

of

biomolecules.4-6

Recently,

nanoparticles are being conjugated to aptamers.7 In chapter 2 and 3, I used
surface modified magnetic nanoparticles for biological applications. Here in this
chapter, I will demonstrate the use of magnetic nanoparticles for analytical
applications. SPIONs are used for immobilizing aptamers via biotin-avidin
chemistry and used as capture tools for steroids in the present work.

Aptamers (also known as molecular recognition elements) are developed by an
in vitro selection process called SELEX.8 SELEX (Systematic Evolution of
Ligands by Exponential Enrichment) is a process wherein the DNA/RNA ligands
are generated from a random pool of modified or unmodified DNA or RNA. The
ligands selected through this process are called aptamers (single stranded
synthetic DNA or RNA capable of folding into unique 3D structures). Aptamers
are widely being used as molecular recognition elements in the fields of
biosensing, diagnostics and therapeutics.9-13 Previously, antibodies were coupled
to nanoparticles for using them in bio-applications.14,

15

However, aptamers

posses additional advantages such as low molecular weights, easy and
reproducible synthesis, low toxicity and high binding affinity and selectivity. The
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ability of aptamers to distinguish targets from subtle structural differences and
bind any target with high affinity made them unique tools in bio-analytical
applications.9, 16

There is an increasing use of aptamers in biosensors for the detection of small
molecules.17-19 Kim et al. discovered a 76 mer DNA aptamer selective to 17βestradiol (E2).20 The chemical structure of 17β-estradiol is shown in figure 4.1.
This aptamer has been proved to have high affinity to estradiol with a
dissociation constant (Kd) of 0.13 µM by electrochemical method. Gioi et al. used
aptamer anchored glass microbeads to preconcentrate estradiol in spiked water
samples and separate bound and unbound fractions using HPLC.21 They
reported a dissociation constant of 35 µM.

In our group, we used 76mer-DNA aptamer to assess its binding affinity with
estradiol using stacking enhanced capillary electrophoresis previously developed
for steroids separation.22 We used streptavidin coated magnetic micro beads as
the capture elements to separate the bound estradiol from the unbound fraction.
In the present work, streptavidin coated magnetic nanoparticles are used as the
capture elements and the separation of bound fraction from the unbound fraction
of estradiol is carried out in a micro capillary. Specific binding conditions (solvent,
ionic strength, pH) used is similar to previous work.23 Samples are analyzed on
capillary electrophoresis (CE) to quantify the bound fraction of estradiol.
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Capillary electrophoresis is an effective microscale separation method. UVvisible absorbance is most commonly used for detection but generally has poor
limit of detection. Stacking and sweeping techniques are used to improve the
detection limits.24 In the present work, pH-mediated stacking method is used for
quantification of estradiol captured by the aptamer.

Use of magnetic nanoparticles and in-capillary separation under strong magnetic
field helps lay out a platform for developing nanoscale devices for detection of
small molecules.

Figure 4-1: Chemical structure of 17β-estradiol (E2)
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4.1.1Theory of Capillary electrophoresis
Electrophoresis is migration of ions in solution under the influence of electric
field. When a charged molecule (q) is placed in a constant electric field E, it
experiences an accelerating force qE and a retarding frictional force fu, where u
is velocity of the ion and f is friction coefficient.

(Accelerated force) qE = fu (frictional force)…………………………… Equation 4.1
U = q/f E = µep E..................................................................................Equation 4.2

Where µep is electrophoretic mobility. It is a proportionality constant between
velocity of ion and electric field strength.

Figure 4-2: Charged molecule placed in a constant electric field experiencing
different types of forces
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In capillary electrophoresis (CE), sample is injected into a fused silica (SiO2)
capillary filled with running buffer and high voltage is applied to separate the
components. All the solutes migrate with different mobilities and separation occur
based on size to charge ratio. Electrophoretic mobility and electro-osmotic flow
dictates the separation in CE. A block diagram of capillary electrophoresis is
shown in figure 4-3.

Figure 4-3: Block diagram of capillary electrophoresis
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At pH above ~ 2.5, the silanol groups in the capillary are deprotonated and
posses negative charge. This attracts the cations in the solution to the negative
surface to partially neutralize the charge. This forms an electric double layer at
the capillary wall. Electroosmotic flow (µos) is a uniform plug like flow of solute
molecules towards cathode driven by the cations in diffuse double layer in the
capillary. A pictorial representation of electro-osmotic flow is shown in figure 4-4.

Figure 4-4: Representation of Electro-osmotic flow

Electrophoretic mobility (µep) is the migration of charged ions under the influence
of applied electric field. It is directly proportional to the charge on the ion (q) and
inversely proportional to the frictional coefficient (f). A pictorial representation of
electrophoretic mobility is shown in figure 4-5. The apparent or observed mobility
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of the analytes is the sum of electro-osmotic flow and electrophoretic mobility
given by equation 4.3.

Apparent mobility (µapp) = µep + µos……………………………………….Equation 4.3

The movement of analytes due to applied voltage from anode to cathode is
normal polarity (shown in figure 4-5). The opposite setting is referred to as
reverse polarity.

Figure 4-5: Representation of Electrophoretic mobility

4.1.2 Advantages of CE
Capillary electrophoresis is a well known separation technique which offers
several advantages.25,
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There is no stationary phase in CE and the flow of
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sample in the open capillary tube is a plug flow as opposed to hydrodynamic flow
in a chromatographic column. This eliminates the longitudinal diffusion and mass
transfer mechanisms involved in the chromatographic separations. Hence, CE
provides high efficiency and resolution. Since CE uses micron size capillaries, it
requires extremely small sample volumes (as low as microliters to nanoliters).
The processing time of samples is faster than other separation techniques like
chromatography. CE can be used for separation and analysis of a wide range of
analytes both charged as well as neutral. It is especially a useful tool for
analyzing biomolecules such as proteins and nucleic acids.27-29

4.1.3 Micellar electrokinetic chromatography (MEKC)
Micellar electrokinetic chromatography (MEKC) is a type of CE which includes a
pseudo stationary phase of micelles. It offers many advantages over capillary
zone electrophoresis.30 MEKC separates neutral molecules and ions. Surface
active agents or surfactants form micelles above their critical micellar
concentrations. Surfactants can be anionic, cationic, zwitterionic and neutral. Any
of these types or a combination can be used as pseudo stationary phase in
MEKC. Sodium dodecyl sulfate (SDS), an anionic surfactant, is extensively used
in MEKC. The electrophoretic mobility of negatively charged micelles is from
cathode to anode while the electro-osmotic flow is from anode to cathode. The
apparent mobility of the micelles is towards cathode as EOF is dominant. The
migration time of neutral analytes depends on their partitioning between the
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micelles. Cyclodextrins (CD) are neutral, inert and stable cyclic oligomers of α-Dglucose with a hollow cavity. They are widely used for separation of optical
isomers and enantiomers.31-33 The interior of cyclodextrin is non-polar and hence
accommodates hydrophobic neutral analytes while the exterior is polar making it
soluble in water. Cyclodextrins move along with EOF as they are neutral. These
molecules have low UV absorptivity at short wavelengths.

Figure 4-6: Strutures of sodium dodecyl sulfate and cyclodextrin
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4.1.4 Instrumentation
The basic instrumentation of capillary electrophoresis includes a micron size
fused silica capillary with the two ends placed in buffer reservoirs containing
platinum

electrodes.

The

sample

is

injected

into

the

capillary

either

hydrodynamically by applying pressure or electrokinetically by applying voltage
on injection side. In normal polarity, sample is injected from anode to cathode. In
reverse polarity, sample is injected from cathode to anode. The detector is
placed on the outlet side of the capillary. Most of the instruments commonly have
UV-Visible detector. However, fluorescence and electrochemical detectors can
also be used on CE. The photographs of CE instrumentation are shown in figure
4-7. The plot obtained from the detector response is known as electropherogram.
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Figure 4-7. Photographs of the Beckman® automated capillary electrophoresis
machine used in the work. The light source is a UV-visible absorbance, with a
PMT or PDA detector.
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4.2 Materials and methods
4.2.1 Reagents and materials
The biotinylated DNA aptamer was synthesized by IDT (Coralville, IO, USA).
Sodium hydroxide, sodium chloride, potassium chloride, sodium dodecyl sulfate
(SDS), carboxymethyl-β-cyclodextrin, testosterone, and 3-[cyclohexylamino]-1propanesulfonic acid (CAPS) were purchased from Sigma-Aldrich (St. Louis, MO,
USA). Streptavidin modified superparamagnetic iron oxide nanoparticles
(SHS30) were purchased from Ocean Nanotech (Springdale, AR, USA).
Methanol was purchased from EMD Biosciences (La Jolla, CA, USA). 17βestradiol and estrone were purchased from Steraloids, Inc. (Newport, RI, USA).
17α-ethynyl estradiol was purchased from Cayman Chemical (Ann Arbor, MI,
USA). Hydroxypropyl-β-cyclodextrin (HPCD) was purchased from VWR (West
Chester, PA, USA). Hydrochloric acid, magnesium chloride, and sodium
phosphate monobasic salt were purchased from Fisher Scientific (Fair Lawn, NJ,
USA). Tris hydrochloride was purchased from Mallinckrodt Maker Inc.
(Phillipsburg, NJ, USA). Neodymium block magnet BX8X8X8-N52 (1 1/2" x 1 1/2"
x 1 1/2" thick) used for separation of SPIONs was purchased from K & J
magnetics, inc. (Jamison, PA, USA). Deionized water was obtained from an Elga
Purelab ultra water system (Lowell, MA).

4.2.2 Instrumentation
Separations were performed using a Beckman Coulter P/ACE MDQ capillary
electrophoresis instrument (Beckman Coulter, Fullerton, CA, USA) shown in
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Figure 4-7. The P/ACE MDQ was equipped with a photodiode array (PDA) for
UV-visible absorbance detection which provided simultaneous determination of
steroids at multiple wavelengths of 200, 225, 254 nm. An Oven was used in
sample preparation for incubation for biotin-streptavidin release. Centrifugation
was performed on a picofuge (Stratagene, La Jolla, CA, USA). A vacuum
centrifuge (Savant, NY, USA) is used for the drying of 10% ethanol solution in the
sample preparation. The Thermo Scientific Nanodrop 1000 is used to determine
DNA concentration in the samples.

4.2.3 DNA aptamer
The DNA aptamer (GCT TCC AGC TTA TTG AAT TAC ACG CAG AGG GTA
GCG GCT CTG CGC ATT CAA TTG CTG CGC GCT GAA GCG CGG AAG C)
was synthesized with a biotin connected to the 5’ base via a 15 atom spacer arm
(tetra-ethyleneglycol). The aptamer was reconstituted at a concentration of 10
μM in a binding buffer similar to that previously reported (200 mM NaCl, 10 mM
MgCl2, 25 mM, KCl, 5% ethanol, 100 mM Tris-HCl buffered at pH 8) .20

4.2.4 Capillary Electrophoresis separation conditions
30 cm long fused-silica capillary with an inner diameter of 25 um and outer
diameter of 360 um (Polymicro Technologies, LLC, Phoenix, AZ, USA) is used
for separations. The detection window was placed at 10.2 cm from the site of
injection. The capillary is maintained at 25 ºC during all the flushes and runs. The
separation buffer used comprised of 30 mM SDS, 13 mM hydroxypropyl-β-
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cyclodextrin, 200 mM phosphate buffered at pH 2.5. Reverse polarity at 16 kV is
used for separation (cathode at the point of injection and anode at the outlet).

4.2.5 Binding experiment
The biotinylated aptamer is coupled to 30 nm size streptavidin coated SPIONs. In
this experiment, 50 µL of SPIONs with a concentration of 1 mg/mL is taken. An
approximate binding capacity of 850 picomoles of single-stranded oligonucleotide
per mg nanoparticles was reported by the manufacturer. Approximately 50 µL of
SPIONs can bind to 40 picomoles of biotinylated DNA. 50 µL SPIONs was
passed through magnet and reconstituted in 20 µL of binding buffer. Therefore,
the DNA binding concentration of SPIONs is 2 µM (40 picomoles).

The aptamer is denatured at 90 ºC for 10 mins in binding buffer and cooled to
room temperature (shown in figure 4-8). The estradiol is added to denatured
DNA at the specified concentration and incubated for 1 hr at 25 ºC. A sample of
SPIONs is taken into a microcapillary by capillary action and held in a high
magnetic field (on the edge of a strong magnet) for about 20 min. The glass
microcapillary used in this procedure can hold 100 µL volumes. It is
approximately 11.5 cm long and 340 µm in diameter. During the waiting period
SPIONs settle down on the sidewall and the supernatant is eluted using a rubber
bulb with a 10-100 µL plastic pipette tip. Low quality SPIONs having differences
in size and magnetic nature are discarded in the supernatant. SPIONs were then
reconstituted deionised water. Later the aptamer-estradiol complex is added to
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washed SPIONs and incubated for 30 mins. After incubation, solution is filled in a
microcapillary and held in a high magnetic field about 20 min. The unbound DNA
and estradiol is washed off the SPIONs by reconstituting with binding buffer,
placing on the magnet and eluting the supernatant. This removes any residual
DNA or estradiol. The washing procedure is shown in figure 4-9. The washed
SPIONs are reconstituted in 10% ethanol. To release the DNA bound to the
SPIONs, they are heated at 70 ºC for 10 min. Heating at this temperature
reportedly dissociates biotin-streptavidin interaction.34 The solution is cooled to
room temperature and pulled into micro capillary which is placed on the edge of
the magnet. The SPIONs are held in place by the magnet; the solution is eluted
into a vial, and dried in a vacuum centrifuge. The dried estradiol is then
reconstituted by stack buffer comprised of 1mM carboxymethyl-β-cyclodextrin
and 100 mM CAPS buffered at pH 10. The sample is then injected into
separation capillary using the sample stacking method previously reported.22 This
stacking mechanism is proved to increase the steroid concentration by 10 fold.
The schematic of the experimental procedure is represented in figure 4-10.

4.2.6 Separation mechanism
The running buffer filled in the capillary is 200 mM phosphate buffer at pH 2.5
comprised of 30 mM SDS and 13 mM HPCD. The stacking buffer used is 1mM
CMCD in 50 mM CAPS buffered at pH 10 with 5% methanol. Methanol aids in
solubilization of hydrophobic steroids. The estradiol steroid is electrokinetically
injected into the capillary by applying 10 kV high voltage at reversed polarity for
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60 sec. At high pH of the stacking buffer, CMCDs are deprotonated and carry the
neutral steroids. As the sample in stacking buffer is injected, it forms a pH
junction in the capillary concentrating the neutral steroid-CMCD complex.
Electro-osmotic flow is insignificant in the capillary which slows down the
movement of neutral molecules such as HPCD. Electrophoretic mobility helps in
the movement of negatively charged SDS molecules. The steroids partition
between negatively charged SDS and CMCDs and are separated at 16kV under
reverse polarity. A schematic of separation mechanism is shown in figure 4-11.
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Figure 4-8: Denaturing of DNA aptamer and its renaturing at room temperature
followed by incubation with estradiol and SPIONs
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Figure 4-9: Schematic of SPIONs washing procedure
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Figure 4-10: Schematic of binding affinity study of 76mer with estradiol using
SPIONs as capture elements

Low quality SPIONs from
the stock were discarded
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Figure 4-11: Schematic of pH mediated micellar electrokinetic chromatography
(MEKC) stacking of estradiol. Separation buffer used was pH 2.5 phosphate
buffer containing sodium dodecyl sulfate (SDS) and Hydroxypropyl cyclodextrin
(HPCD). Stack buffer used is pH 10 CAPS buffer containing Carboxymethyl
cyclodextrins (CMCD)
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4.3 Results and discussion
4.3.1 Aptamer binding
Aptamer immobilized on SPIONs is incubated with concentrations of estradiol
ranging from 18 µM to 95 µM to determine the binding affinity. The unbound
estradiol is removed by washing with the binding buffer. Binding buffer is used to
maintain the right confirmation of aptamer. The estradiol bound to the aptamer on
SPIONs is released into 10% ethanol by heating at 70 ºC. This solution is dried in
the vacuum centrifuge. It is then reconstituted in stack buffer and quantified by
sample stacking and capillary electrophoresis. This process of drying and
reconstituting ensures the volumes of the samples is the same and there is no
loss of estradiol during elution step. Standard addition is used to quantify the
estradiol binding in each sample.

4.3.2 Standard addition method
In standard addition, known concentration of estradiol is added to each sample.
The amount of unknown estradiol is deduced from the increase in analytical
signal. The response to increasing concentrations of added known estradiol
produced a linear response. Since the sample preparation involves use of
nanoparticles and multiple washing steps with high salt containing buffer, the
matrix affects the analytical signal. Hence, standard addition method is more
appropriate to these samples. The assumption is that the matrix effect is same
on added estradiol as it has on the original estradiol concentration in the
unknown.
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4.3.3 DNA determination
The DNA concentration in each sample is determined using Thermo Scientific
Nanodrop 1000 using stacking buffer spiked with steroid as the blank. Nanodrop
1000 is a UV-vis spectrophotometer which can provide full spectrum data (200800 μm). It has a compact design and uses very small volumes of samples (0.5 –
2.0 μL). It is especially used for nucleic acid or protein concentration
measurements. Though the DNA concentration introduced initially in each
sample is the same, the concentration varies during the sample preparation due
to loss of nanoparticles in washes. So, the DNA recovered from each sample is
normalized by dividing the concentration in a single set by lowest concentration
of DNA within the set. The bound estradiol is then divided by this factor.
Assuming the relative losses of DNA on all the samples is same, concentration is
normalized based on lowest DNA concentration.

4.3.4 Plotting data
The specific binding curve is obtained by plotting normalized estradiol bound to
DNA against free estradiol used initially. The data was fit on GraphPad Prism
version 4 using one-site binding model described by the equation, Y= ((Bmax * X)/
(Kd + X)) + NS* X , where Bmax is the maximal binding and Kd is the dissociation
constant and NS is the non-specific binding.
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4.3.5 Non-specific binding
The non specific binding curve is done using a 37 base reverse E2 primer ( 5’GCT TCC GCG CTT CAG CGC -3’) of the aptamer. The added reverse
compliment couples to part of the estradiol aptamer with 76 bases. So, the
aptamer is not in the right configuration and the estradiol binding to this complex
is considered as non-specific binding. Non-specific binding also includes the
estradiol binding to the surface of nanoparticles as well. The value of non-specific
binding was estimated using slope of the curve 0.0013.

Nonlinear regression analysis of the binding curve gave a dissociation constant
of Kd = 11 ± 4 μM and Bmax = 0.43 ± 0.03 μM with an R2= 0.908. The binding
curves are repeated three times to ensure the reproducibility of the results. The
results are shown in the table 4-2 with Kd and Bmax values. The binding curves
are shown in figure 4-13.

4.3.6 “Magnetic micro particles” Vs “magnetic nanoparticles”
Previously, the binding affinity of the 76 mer aptamer to estradiol is determined
using magnetic microbeads with streptavidin surface to aid the immobilization of
aptamer.23 The size of the microbeads used in our previous work is 1um
(1000nm). An approximate binding capacity of 500 picomoles of single stranded
20 base pair biotinylated oligonucleotide per mg of bead was reported by the
manufacturer. The volume of beads used was 40 µL (concentration 5 mg/ml).
Thus, these beads can bind a maximum DNA concentration of ~2 μM (80
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picomoles). There is no shelf life for these beads. Microbeads are easy to
concentrate in solution by placing them on magnet due to their larger size. The
larger size of beads also tends to cause less loss of beads during sample
preparation steps. The Kd value reported with magnetic microbeads is Kd = 70 ±
10 μM and a Bmax = 0.42 ± 0.03 μM.

In the present paper, superparamagnetic iron oxide nanoparticles (SPIONs) of 30
nm size with streptavidin surface are used. The SPIONs purchased have a shelf
life of three months and noticeably they did not give good results after the
expiration date. The aptamer is immobilized on streptavidin modified SPION
surface and the bound and unbound estradiol separation during the sample
preparation is done in a micro capillary. The smaller size of SPIONs accounts for
their greater stability in solution and the time required to concentrate them on a
magnet is much higher compared to microbeads. The loss of nanoparticles
during the sample preparation is more due to sticking of SPIONs to glass micro
capillary and the eppendrof tubes used for reconstitution of samples.

From the experimental results obtained with SPIONs, Kd = 11 ± 4 μM and Bmax =
0.43 ± 0.03 μM. It is shown that the binding affinity constant Kd of the aptamer is
approximately 8 times lesser than that obtained using the magnetic micro beads
which tells that the binding of estradiol to aptamer immobilized on SPIONs is
occurring at a higher rate. This can be explained by the higher surface area of
the nanoparticles and compact packing of biotinylated aptamer on the
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streptavidin coated nanoparticles. The comparison of Kd and Bmax obtained from
two studies are shown in table 4-1.

Table 4-1: Comparison of Kd and Bmax values obtained from the aptamer binding
studies done using magnetic micro and nano particles.

Dissociation constant
Capture elements

Non-specific
Bmax

(Kd )

binding slope

SPIONs

11 ± 4 μM

0.43 ± 0.03 μM

0.0013

microbeads

70 ± 10 μM

0.42 ± 0.03 μM

0.0016
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Figure 4-12: Representative electropherogram showing a single standard
addition determination. DNA in the sample is separated from estradiol and is
represented by the peak at 1.75 min. Inset shows the traces of bound estradiol.
The known concentrations of estradiol added to the sample gave a linear
response. The concentration of the unknown estradiol in the sample is then
calculated.
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Figure 4-13: Represents three determinations of binding affinity of 76mer
aptamer and steroids using SPIONs as capture elements. The ratio of bound
estradiol to total DNA is plotted on the y-axis and initial free concentration of
estradiol is plotted on x-axis. The equation used to fit non-linear data is Y= ((Bmax
* X)/ (Kd + X)) + NS* X, where Bmax is the maximal binding and Kd is the
dissociation constant and NS is the non-specific binding.
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Table 4-2: Raw Data Used for each Binding Isotherm
Total E2

Total DNA

Set 1
18
0.65
30
0.81
48
1.18
65
0.54
83
0.83
95
0.58
Kd = 11 ± 4
Bmax = 0.43 ± 0.03
Set 2
18
30
48
83
95

0.57
1.05
0.78
0.79
0.95
Kd = 9 ± 4
Bmax = 0.26 ± 0.02

Set 3
18
0.75
30
1.41
48
0.77
65
0.66
95
1.24
Kd = 10 ± 6
Bmax = 0.32 ± 0.04

Bound E2

uncertainty

Free E2

Normalized
Bound E2

0.36
0.56
0.81
0.49
0.74
0.56
2
R = 0.908

0.06
0.06
0.08
0.05
0.08
0.07

17.64
29.44
47.19
64.51
82.26
94.44

0.29
0.37
0.37
0.49
0.48
0.52

0.19
0.42
0.42
0.46
0.57
R2 = 0.941

0.04
0.03
0.05
0.03
0.06

17.81
29.58
47.58
82.54
94.43

0.19
0.23
0.31
0.34
0.34

0.24
0.61
0.43
0.38
0.72
2
R = 0.847

0.02
0.03
0.04
0.02
0.05

17.76
29.39
47.57
64.62
94.28

0.21
0.29
0.37
0.38
0.38

All data reported in micromolar.

Chapter 4

102

4.4 Conclusions and future directions
We have developed an effective method of capturing estradiol using aptamer
anchored magnetic nanoparticles. SPIONs are proven to be effective platform for
analytical sensing. Furthermore, this method can be extended to other small
molecules for which aptamers have been developed. Using different aptamers,
multiple compounds can be separated. This will help in detecting multiple
compounds in a variety of samples using micro scale devices. SPIONs could be
easier to incorporate in micro or nano scale biosensors. This work can be
considered as a preliminary study to show that the magnetic nanoparticles can
be more effective separation tools compared to microbeads. Further studies on
using aptamers for separation of steroids in-capillary are being conducted.
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